FDA
Empagliflozin; Linagliptin; Metformin Hydrochloride
The FDA lists this product in 4 strengths and forms.
Composition
- Active ingredients
- EMPAGLIFLOZIN 12.5MG; LINAGLIPTIN 2.5MG; METFORMIN HYDROCHLORIDE 1000MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- EMPAGLIFLOZIN 12.5MG; LINAGLIPTIN 2.5MG; METFORMIN HYDROCHLORIDE 1000MG · Tablet, extended releaseThis page
- EMPAGLIFLOZIN 5MG; LINAGLIPTIN 2.5MG; METFORMIN HYDROCHLORIDE 1000MG · Tablet, extended releaseANDA217049-001 · Tentative approval
- EMPAGLIFLOZIN 25MG; LINAGLIPTIN 5MG; METFORMIN HYDROCHLORIDE 1000MG · Tablet, extended releaseANDA217049-004 · Tentative approval
- EMPAGLIFLOZIN 10MG; LINAGLIPTIN 5MG; METFORMIN HYDROCHLORIDE 1000MG · Tablet, extended releaseANDA217049-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA217049.